Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L - Wikidata - wikimedia - TriplyDB

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L

http://www.wikidata.org/entity/Q42194180

about

Neutrophils in Cancer: Two Sides of the Same Coin Hemogram responses in goats toward challenged with Corynebacterium pseudotuberculosis and its immunogen mycolic acids Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha).Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.Granzyme B-expressing neutrophils correlate with bacterial load in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques.Bladder Cancer Immunotherapy: BCG and Beyond.TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice.Transformation, translation and TRAIL: an unexpected intersection.Role of neutrophils in BCG immunotherapy for bladder cancer.CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer.Therapeutic applications of TRAIL receptor agonists in cancer and beyond.Immunotherapy for urothelial carcinoma: current status and perspectives.TRAIL gene therapy: from preclinical development to clinical application.Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder.TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.Potential therapeutic anti-tumor effect of a Salmonella-based vaccine.Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors.Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer.Regulation of the human TRAIL gene.The mechanism of action of BCG therapy for bladder cancer--a current perspective.Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence.Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette-Guérin.Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer.The Role of Neutrophils in Measles Virus-mediated Oncolysis Differs Between B-cell Malignancies and Is Not Always Enhanced by GCSF.Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages.IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancer.Pleural Effusion Caused by Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer.Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.Gene expression disorders of innate antibacterial signaling pathway in pancreatic cancer patients: implications for leukocyte dysfunction and tumor progression Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination.Isoproterenol Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Embryonic Kidney Cells through Death Receptor 5 up-Regulation.Synergistic Cytotoxic Effects of Ganoderma lucidum and Bacillus Calmette Guérin on Premalignant Urothelial HUC-PC Cells and Its Regulation on Proinflammatory Cytokine Secretion.Aorto-enteric fistula development secondary to mycotic abdominal aortic aneurysm following intravesical bacillus Calmette-Guerin (BCG) treatment for transitional cell carcinoma of the bladder.Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer.

P2860

Q26773072-8D3A8EED-F3AA-4E70-87DD-A4D89DA13FCE Q33877166-09CE7F5F-1FFF-4CAB-ADFD-31D7D0D8D7D2 Q34384021-70689194-4305-439C-A226-EF601B5D5C7D Q34644769-E2CEFB10-3BAF-4ECD-9627-442CB6417D9D Q34963231-3D758934-8E84-461B-8DB7-884100D4D613 Q35215350-39E10D0F-E962-4195-ADAE-10B7AAED4E57 Q35591514-18D5FF06-4A03-4803-904C-D1D464FA9176 Q35689498-5BBB048C-5640-490D-9DAA-57B532D2A260 Q36056007-4F5384A7-76C6-46D9-9BD2-07202A53AE57 Q36062297-046058B4-FC79-4C3E-97A0-9A243C910BB8 Q36072179-48FEFF12-60CE-4BE8-B2CA-1668E3C194CC Q36340830-4B055C4F-800B-4C90-B20B-386DFE77E125 Q36571532-DC02EFE4-8DAD-4B6D-96D8-66B86EA77B43 Q36803793-6EDEC157-B8B7-466D-8002-DC4FF98C3C48 Q36915014-CEF3116D-F8FD-4FAB-B0AB-5902BFE61756 Q37114025-2F609EEC-8A0A-48F3-90BB-337C99E8E3C0 Q37137381-A3A427C1-7570-4E39-837D-10A9445BC69E Q37307340-CEED82D9-ECA8-40F7-AE27-FD43BC347E4E Q37352975-837572BA-5F90-402A-A781-91C468071F87 Q37440765-D80067D2-9A99-46EA-865E-634690433934 Q37530067-E41C105D-6762-410B-B96E-FEF132228E93 Q37646545-C53C54FC-3625-41D6-BDD5-A99E059709C1 Q37655607-935B6AE4-8640-4D1A-AA4C-B6E637C0002B Q37739809-2906AE1B-405B-4F30-80C7-A502E4CF41EF Q38034651-DCF1411B-AC97-4DC1-BF4A-BB9C354FF706 Q38184849-571755F9-FC2A-440D-99F8-6444C9B6204A Q38197678-9D072CBB-532F-4B0A-9796-025B56631153 Q38232854-5B212442-5138-4747-958A-ADAFCE61215A Q38385719-2AD0346A-3FD6-46C5-81D2-69F0CB3F1E1C Q38471494-F183D4E3-D124-4D1A-A3A7-2B9330AB795C Q38979660-FC9C8314-355F-4540-A039-23A92505B863 Q39616587-FED1E12D-650D-4494-ACCA-D2E37CB389B9 Q40111881-A3F04060-0CE4-4BFC-ACC9-6B024D621827 Q40318203-A4365C34-C215-44A4-921A-49CDF130DB9A Q40923346-D2A1B99C-CD51-4E7C-8134-47EDFC450A1E Q41275498-CB58EE62-265D-4D3C-B3CB-11D14E1AA593 Q41901744-EDF5FB67-81D5-421B-B5A0-07FCF70618C3 Q42323227-D91FA6A2-49AB-48BF-90DB-721F6519BFC0 Q42535091-F3D062AF-6071-49E1-9C2C-AE70A2229C7B Q46851166-904CCA22-702D-48F5-830B-DDE2A08E9D50

P2860

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L

http://www.wikidata.org/entity/Q42194180

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Neutrophil stimulation with My ...... unctional soluble TRAIL/Apo-2L

@en

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin

@nl

type

label

Neutrophil stimulation with My ...... unctional soluble TRAIL/Apo-2L

@en

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin

@nl

prefLabel

Neutrophil stimulation with My ...... unctional soluble TRAIL/Apo-2L

@en

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin

@nl

P1433

Q42194180-F1823424-6156-4F25-A2FB-81929C8D2D9D

P1476

Q42194180-F88DA606-0E82-4B9D-8426-B62C1B5C01E2

P2093

Q42194180-0796289E-DDD2-45A8-8012-9869A7ECEE23

Q42194180-376220B8-9471-4266-B166-EFC77E3243E2

Q42194180-38C8B767-A614-472C-92EF-2C3263F019BC

Q42194180-5547D886-2549-4056-A19F-908008F09A9C

Q42194180-557C125F-C20B-437A-87FF-845EA2C4930E

Q42194180-91F8B17A-01BF-4762-9FB1-26C2A209AE7E

Q42194180-A2499955-ABB2-4442-84BF-D148F551075E

Q42194180-A89F90BC-66B0-4D00-BC17-CC29999C3749

Q42194180-F3457A27-EF9E-42C3-9D7B-4819901425DB

P2860

Q42194180-00903E8C-4959-4120-9D60-05DE62903FC6

Q42194180-0AA41477-E375-4762-8279-11D2B8C1D9C6

Q42194180-0EC523E1-BF24-4B74-A895-CB12F8D1B7A2

Q42194180-0ECB82B2-FCF0-4CCB-92D3-9E3FDA9F6B77

Q42194180-102171B5-9D6C-4711-B250-63D02988AA51

Q42194180-17D40E7C-17F8-4B6B-BB04-8CF54A261081

Q42194180-1ABEED93-B5B2-4C87-B054-33CC702C99A1

Q42194180-1DE938CF-50AE-4E7B-B668-FC8B84168C6D

Q42194180-26518061-BE72-4F1B-9E00-DF2984F81584

Q42194180-2EC5CFF7-BA97-494E-88EE-8DBDA1BA642D

P304

Q42194180-ABC59C39-B8C7-42C1-888B-62D965B6EEF8

P31

Q42194180-C89CAABE-621D-4A68-AD63-730D5446DEED

P356

Q42194180-C9803F12-404B-4579-8FDB-05C8D6F8833B

P407

Q42194180-073BE526-FCED-4D29-BED4-724A8BF504C2

P433

Q42194180-101F8342-6E1A-4C92-8DF5-C906CE62B65B

P478

Q42194180-2BBCA5A1-50ED-4EC9-9D41-65B2198B6EB6

P577

Q42194180-D184EDA3-05B0-42BF-9EEB-D42CDE778719

P5875

Q42194180-A0672C61-8868-421D-A24C-9C1008FE9981

P698

Q42194180-51563EC5-6631-422E-8D59-77A947104E00

P932

Q42194180-5A975A25-DCFE-4D37-919E-0AD70D68B1EC

P356

BLOOD-2005-03-1327

P1433

P1476

Neutrophil stimulation with My ...... unctional soluble TRAIL/Apo-2L

@en

P2093

Aaron T Ludwig

http://www.w3.org/2001/XMLSchema#string

Bonita Moses

http://www.w3.org/2001/XMLSchema#string

James K Earel

http://www.w3.org/2001/XMLSchema#string

Jill M Moore

http://www.w3.org/2001/XMLSchema#string

Kevin Leidal

http://www.w3.org/2001/XMLSchema#string

Rebecca L Vanoosten

http://www.w3.org/2001/XMLSchema#string

Thomas S Griffith

http://www.w3.org/2001/XMLSchema#string

Troy J Kemp

http://www.w3.org/2001/XMLSchema#string

William M Nauseef

http://www.w3.org/2001/XMLSchema#string

P2860

The complete genome sequence of Mycobacterium bovis

Identification and characterization of a new member of the TNF family that induces apoptosis

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

Toll-like receptors: critical proteins linking innate and acquired immunity

New use of BCG for recombinant vaccines

Cancer statistics, 2004

Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors.

Neutrophil-derived proteins: selling cytokines by the pound.

Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: their practical use.

Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages

P304

3474-3482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-03-1327

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7708698

http://www.w3.org/2001/XMLSchema#string

P698

16037389

http://www.w3.org/2001/XMLSchema#string

P932

1895062

http://www.w3.org/2001/XMLSchema#string